Logo image of ORIS

ORIENTAL RISE HOLDINGS LTD (ORIS) Stock Fundamental Analysis

NASDAQ:ORIS - Nasdaq - KYG6781A1022 - Common Stock - Currency: USD

0.088  -0.01 (-5.38%)

Fundamental Rating

4

Taking everything into account, ORIS scores 4 out of 10 in our fundamental rating. ORIS was compared to 91 industry peers in the Food Products industry. ORIS is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. ORIS has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year ORIS was profitable.
In the past year ORIS had a positive cash flow from operations.
ORIS Yearly Net Income VS EBIT VS OCF VS FCFORIS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2M 4M 6M 8M 10M

1.2 Ratios

ORIS has a better Return On Assets (5.93%) than 76.92% of its industry peers.
With a Return On Equity value of 6.10%, ORIS perfoms like the industry average, outperforming 53.85% of the companies in the same industry.
ORIS has a Return On Invested Capital (4.78%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for ORIS is significantly below the industry average of 28.16%.
The last Return On Invested Capital (4.78%) for ORIS is well below the 3 year average (11.00%), which needs to be investigated, but indicates that ORIS had better years and this may not be a problem.
Industry RankSector Rank
ROA 5.93%
ROE 6.1%
ROIC 4.78%
ROA(3y)13.65%
ROA(5y)N/A
ROE(3y)14.57%
ROE(5y)N/A
ROIC(3y)11%
ROIC(5y)N/A
ORIS Yearly ROA, ROE, ROICORIS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 5 10 15 20

1.3 Margins

The Profit Margin of ORIS (18.84%) is better than 96.70% of its industry peers.
ORIS's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 18.73%, ORIS belongs to the top of the industry, outperforming 94.51% of the companies in the same industry.
ORIS's Operating Margin has declined in the last couple of years.
ORIS has a Gross Margin of 29.04%. This is in the better half of the industry: ORIS outperforms 63.74% of its industry peers.
In the last couple of years the Gross Margin of ORIS has declined.
Industry RankSector Rank
OM 18.73%
PM (TTM) 18.84%
GM 29.04%
OM growth 3Y-31.11%
OM growth 5YN/A
PM growth 3Y-30.79%
PM growth 5YN/A
GM growth 3Y-20.11%
GM growth 5YN/A
ORIS Yearly Profit, Operating, Gross MarginsORIS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 10 20 30 40 50

More info and screens

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ORIS is creating some value.
The number of shares outstanding for ORIS has been increased compared to 1 year ago.
ORIS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ORIS Yearly Shares OutstandingORIS Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M 20M
ORIS Yearly Total Debt VS Total AssetsORIS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 3.10 indicates that ORIS is not in any danger for bankruptcy at the moment.
The Altman-Z score of ORIS (3.10) is better than 69.23% of its industry peers.
ORIS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.1
ROIC/WACC0.62
WACC7.75%
ORIS Yearly LT Debt VS Equity VS FCFORIS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 20M 40M 60M

2.3 Liquidity

ORIS has a Current Ratio of 24.80. This indicates that ORIS is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 24.80, ORIS belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
ORIS has a Quick Ratio of 23.79. This indicates that ORIS is financially healthy and has no problem in meeting its short term obligations.
ORIS has a better Quick ratio (23.79) than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 24.8
Quick Ratio 23.79
ORIS Yearly Current Assets VS Current LiabilitesORIS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for ORIS have decreased strongly by -70.76% in the last year.
The earnings per share for ORIS have been decreasing by -26.95% on average. This is quite bad
ORIS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -42.06%.
ORIS shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -12.44% yearly.
EPS 1Y (TTM)-70.76%
EPS 3Y-26.95%
EPS 5YN/A
EPS Q2Q%-68.19%
Revenue 1Y (TTM)-42.06%
Revenue growth 3Y-12.44%
Revenue growth 5YN/A
Sales Q2Q%-37.76%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ORIS Yearly Revenue VS EstimatesORIS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 0.33, which indicates a rather cheap valuation of ORIS.
ORIS's Price/Earnings ratio is rather cheap when compared to the industry. ORIS is cheaper than 100.00% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.99. ORIS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 0.33
Fwd PE N/A
ORIS Price Earnings VS Forward Price EarningsORIS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

ORIS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ORIS is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 0.65
EV/EBITDA -7.64
ORIS Per share dataORIS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ORIS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ORIENTAL RISE HOLDINGS LTD

NASDAQ:ORIS (8/7/2025, 12:50:04 PM)

0.088

-0.01 (-5.38%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.22%
Inst Owner ChangeN/A
Ins Owners77.23%
Ins Owner ChangeN/A
Market Cap1.94M
AnalystsN/A
Price TargetN/A
Short Float %1.92%
Short Ratio0.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.33
Fwd PE N/A
P/S 0.09
P/FCF 0.65
P/OCF 0.6
P/B 0.03
P/tB 0.03
EV/EBITDA -7.64
EPS(TTM)0.27
EY306.82%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.14
FCFY153.75%
OCF(TTM)0.15
OCFY167.07%
SpS1.03
BVpS3.19
TBVpS3.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.93%
ROE 6.1%
ROCE 6.05%
ROIC 4.78%
ROICexc 12.32%
ROICexgc 12.32%
OM 18.73%
PM (TTM) 18.84%
GM 29.04%
FCFM 13.11%
ROA(3y)13.65%
ROA(5y)N/A
ROE(3y)14.57%
ROE(5y)N/A
ROIC(3y)11%
ROIC(5y)N/A
ROICexc(3y)22.86%
ROICexc(5y)N/A
ROICexgc(3y)22.86%
ROICexgc(5y)N/A
ROCE(3y)14.51%
ROCE(5y)N/A
ROICexcg growth 3Y-34.59%
ROICexcg growth 5YN/A
ROICexc growth 3Y-34.59%
ROICexc growth 5YN/A
OM growth 3Y-31.11%
OM growth 5YN/A
PM growth 3Y-30.79%
PM growth 5YN/A
GM growth 3Y-20.11%
GM growth 5YN/A
F-Score4
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 23.29%
Cap/Sales 1.14%
Interest Coverage 31.04
Cash Conversion 60.36%
Profit Quality 69.6%
Current Ratio 24.8
Quick Ratio 23.79
Altman-Z 3.1
F-Score4
WACC7.75%
ROIC/WACC0.62
Cap/Depr(3y)60.73%
Cap/Depr(5y)N/A
Cap/Sales(3y)3.01%
Cap/Sales(5y)N/A
Profit Quality(3y)117.23%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-70.76%
EPS 3Y-26.95%
EPS 5YN/A
EPS Q2Q%-68.19%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-42.06%
Revenue growth 3Y-12.44%
Revenue growth 5YN/A
Sales Q2Q%-37.76%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-78.57%
EBIT growth 3Y-39.69%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-72.61%
FCF growth 3Y71.83%
FCF growth 5YN/A
OCF growth 1Y-74.39%
OCF growth 3Y-28.66%
OCF growth 5YN/A